Changes in four outcome variables by treatment group
| Baseline at the original study | At the end of the present study | ||||
|---|---|---|---|---|---|
| Ciprofloxacin group (n=26) | Placebo group (n=27) | Ciprofloxacin group (n=26) | Placebo group (n=27) | p Value | |
| *Mean (SD); †median (IQR); ‡number of patients (%). | |||||
| ESR, erythrocyte sedimentation rate; VAS, visual analogue scale. p Value refers to the difference between the ciprofloxacin and placebo groups at the present study. | |||||
| ESR (mm/1st h)* | 56.6 (27.1) | 68.6 (26.2) | 8.0 (7.7) | 9.8 (8.5) | 0.42 |
| Patient’s global assessment (VAS)* | 33.3 (19.0) | 29.8 (17.0) | 9.6 (11.5) | 16.1 (17.7) | 0.170 |
| Ritchie index | 6.7 (3.3)* | 5.9 (2.9)* | 0 (0–0)† | 0 (0–2)† | 0.211 |
| Complete recovery (%)‡ | 0 | 0 | 24 (92) | 16 (59) | 0.006 |